ADC Therapeutics's total assets for Q2 2025 were $321.56M, an increase of 17.99% from the previous quarter. ADCT total liabilities were $520.75M for the fiscal quarter, a 1.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.